News
-
Everyone ages differently: Cardiovascular disease and HIV
The CTN’s HIV and Aging Cohort Study aims to understand how HIV can affect the development of heart…
-
Blood donation criteria due to change for men who have sex with men
By the end of September 2022, there will no longer be blood donation criteria specific to men who…
-
Postdoc Spotlight: Dr. Cara Spence
Dr. Cara Spence began her CTN Postdoctoral Fellowship in 2021, sponsored by CANFAR, embarking on a project investigating…
-
Age, altruism, or a long-term view: Why do people living with HIV get the COVID-19 vaccine?
Understanding COVID-19 vaccine confidence in people living with HIV in Canada
-
How U=U transformed the pregnancy journey
April 24–30 is Canadian Infertility Awareness Week. It wasn’t that long ago that people living with HIV faced…
-
Collaborating to close the gap in women’s health care and research
To mark International Women’s Day, we sat down with the CTN 335 investigators to learn about how their…
-
CTN study tests new drug for the first time in people living with HIV
The drug works against CMV, a common virus that may be a main cause of inflammation and health…
-
Improving anal cancer screening among men living with HIV
Ahead of World Cancer Day, we spoke with Dr. Troy Grennan about anal cancer screening among gbMSM living…
-
Does the COVID-19 vaccine work for people living with HIV?
A new national study, called HIVCOV (CTN 328), will assess COVID-19 vaccine immune responses and effectiveness among people…
Resources
Our Resource Library is a place to share documents, videos, and training resources about HIV and STBBI research and related topics.
-
Public Health Agency of Canada
This surveillance report presents information on first-time diagnoses from all thirteen provinces and territories between 2014 and 2023, and provides robust evidence for the planning, evaluation, and implementation of HIV prevention and care programs and education. This report also presents information on first-time HIV diagnoses and previously diagnosed HIV by province and territory for 2020…
-
Resource CategoriesTypes
Treatment Access Group (TAG)
Welcome to the 2025 Pipeline Report. TAG’s annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
-
Resource Categories
HIV Prevention Trials Network
Gail B. Broder, Associate Director, HVTN Social and Behavioral Science & Community Engagement Unit
-
Resource CategoriesTypes
Pauktuutit
The Community Readiness Model is a tool that can help communities determine how ready they are to deal with a specific issue. This project aimed to adapt, pre-test and use the CRM to identify how ready three communities (Arviat, Clyde River and Kugluktuk) are to deal with HIV.
-
Resource CategoriesTypes
UBC Continuing Professional Development
This course focuses on the science of U=U and how to effectively spread the message in a clear, stigma-free manner.
-
Resource CategoriesTypes
US National Institute of Allergy & Infectious Diseases (NIAID)
This guide includes language suggestions for communicating about HIV and related topics. While it was originally designed to help NIAID staff communicate with empowering rather than stigmatizing language, especially as it relates to HIV, it was quickly recognized that it has value beyond NIAID.
-
Resource CategoriesTypes
National Institutes of Health, CDC
Developed by the National Institutes of Health, the Centers for Disease Control and Prevention, and the HIV Medicine Association of the Infectious Diseases Society of America Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV—A Working Group of the NIH Office of AIDS Research Advisory Council (OARAC)
-
Resource CategoriesTypes
CATIE
CATIE’s HIV and Hepatitis C Testing course aims to develop in-depth knowledge of testing technologies, approaches to testing, and how all service providers play an important role in reaching people with HIV and hepatitis C. Throughout this course, participants learn about the importance of testing for HIV and hepatitis C, what testing technologies exist in…
Studies
The CTN+ supports clinical trials, implementation science projects, and non-interventional research of the highest scientific and ethical standards.
-
CTNPT 055: Testing Immunogenicity and Durability of Mpox Vaccination in People Living with HIV
Vaccines in a Time of Dual Pandemic: COVID-19 Vaccine in People with HIV
-
CTN 343: Project ReportNeedles.ca
Project ReportNeedles.ca: A rapid assessment and response system to map needle prevalence and implement harm reduction interventions in Regina, Saskatchewan
-
CTN 260: Raltegravir switch study
A randomized prospective open-label study of switching to raltegravir based antiretroviral therapy (ART) compared to maintaining ritonavir boosted protease inhibitor-based ART on liver fibrosis progression in HIV-HCV co-infected individuals
Publications
Our researchers and trainees have produced hundreds of peer-reviewed publications in a wide range of HIV- and STBBI-related areas.